Skip to search formSkip to main contentSkip to account menu

mu-Chain Disease

Known as: MU HEAVY-CHAIN DISEASE, MU HEAVY CHAIN DISEASE, IGM HEAVY CHAIN DISEASE 
A clonal disorder characterized by the secretion of a mu heavy chain that lacks a variable region. Most patients present with slowly progressive… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
The CO-displacement of [(mu-pdt)Fe(2)(CO)(6)] with (Ph(2)PCH(2))(2)N(n-Pr) in refluxing toluene gave an unsymmetrical chelating… 
Highly Cited
2002
Highly Cited
2002
Described here are oxidations of alkylaromatic compounds by dimanganese mu-oxo and mu-hydroxo dimers [(phen)(2)Mn(IV)(mu-O)(2)Mn… 
Highly Cited
1999
Highly Cited
1999
Previous measurements in lymph and adipose tissue have indicated that interstitial insulin concentrations are ∼40% lower than in… 
Review
1997
Review
1997
Malarial pigment (haemozoin; HZ) is generally considered to be a non-toxic, high-molecular-weight storage form of undigested… 
Highly Cited
1992
Highly Cited
1992
Classical conditioning of skin conductance responses was studied in 26 healthy volunteers and 31 patients who received general… 
Highly Cited
1984
Highly Cited
1984
A. two‐site immunochemiluminometric assay (ICMA) has been developed for the measurement of human thyrotrophin (TSH). The… 
Highly Cited
1980
Highly Cited
1980
The presence of enkephalins in the intestine and the use of opiates to treat diarrheal diseases suggests that enkephalins may…